Lukang Pharma has launched two new products: Tulathromycin and Levodopa
Shandong Lukang Pharmaceutical Co., Ltd is a leading bio-pharmaceutical enterprise in China.
Shandong Lukang Pharma specializes in the supply of APIs, finished products and the general undertaking of CMO business. Recently, Lukang Pharma has launched two new products, Tulathromycin and Levodopa, and are working on many more.
Established in 1966, Lukang Pharma engaged in bio-pharmaceutical business involves API, human drugs, veterinary drugs and biopesticides.
- API such as Tylosin and Spectinomycin series are widely praised worldwide
- Human drugs cover antibiotics, antidiabetic, antiviral drug, cardio-cerebrovascular drug, neurodegenerative drug and so on
- Biopesticide: Bacillus Thuringiensis, Spinosad (upcoming), Gibberellin
- Undertake CMO and CDMO business.
Why choose Lukang Pharma:
- Sound quality management system, 56 years consistent good quality
- Our workshops take the lead through the ISO 9001, ISO 14001, ISO 45001 system certification.
- Strict regulatory compliance and continual improvement
- High GMP management system such as U.S. cGMP, EU GMP and ICH Q7, as well as Chinese GMP, with all products certified by GMP
- Complete EHS system and high-tech facilities
- Strong production capacity, perfect equipment, advanced techniques, and complete quality supervision system
- 2.7 square kilometers production parks, with over 6000 employees
- API annual output: 20000+tonnes including Fermentation and Synthesis
- Human Drug annual output: 8+billion capsules, 2+billion powder-injections, 1.5+billion tablets
- 3 R&D centres and 5 pilot platforms throughout the country.
Products:
Lukang Pharma has more than 500 types of products, which are of human, veterinary, and agricultural use.
Our new products: Tulathromycin (GMP+DMF)/ LEVODOPA (EP/USP).
Our complete product catalogue
For more information, please contact us at [email protected] or visit our website www.lkpc.com.
![SHANDONG LUKANG PHARMACEUTICAL CO., LTD](https://www.cphi-online.com/TM-comp243513.png)
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance